Dec 16,2022

Roche expands access to diabetes care for financially disadvantaged in local communities

Roche today announced that it has partnered with charity organisation, Diabetes Singapore, to launch the Access to Care programme in support of people with diabetes from lower-income groups who need a helping hand with regular self-monitoring of blood glucose (SMBG), a move that is crucial to keep their blood glucose levels in range. The programme is a step towards making structured SMBG more accessible and affordable to help ease the financial burden on lower-income groups in Singapore, as blood glucose monitoring supplies are recurring out-of-pocket expenses.

COLLABORATION PARTNERSHIP

#institution

#bgm

View Analyst & Ambassador Comments
Go to original news
Nov 03,2022

Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)

Senseonics Holdings, Inc. and Ascensia Diabetes Care, exclusive distributor of Eversense® CGM Systems, today announced the launch of a collaboration with the Nurse Practitioner Group (NPG), a leader in multidisciplinary health services and medical staffing solutions. Senseonics, Ascensia and NPG view this collaboration as a scalable solution with the goal of expanding access to the Eversense E3 CGM System, enhancing the patient experience, streamlining the Eversense workflow for health care providers who elect not to do insertions themselves, thus broadening the universe of clinicians who prescribe Eversense.

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Nov 16,2022

Marpai Announces Virta as Diabetes Premium Health Partner

Marpai, Inc., an AI-technology company transforming self-funded employer health plans, announces the addition of Virta Health as a Premium Health Partner to improve health outcomes for health plan members with diabetes. Under its universal Marpai Cares offering for self-funded health plans, Marpai delivers Proactive Targeted Health Interventions aimed at improving health outcomes and trajectories for at-risk health plan members. After rigorous analysis by Marpai data scientists and clinicians, Virta has been selected as the clinical solution for treating diabetes.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Feb 02,2022

UCI Health Partners with Biofourmis for Hospital at Home and Post-Acute Remote Patient Monitoring

Biofourmis announced a multi-year agreement with UCI Health to support continuous artificial intelligence (AI)-powered remote monitoring of acute and post-acute care patients in their homes through Biofourmis tools. UCI Health comprises the clinical enterprise of the University of California, Irvine and is Orange County’s only academic health system. Biofourmis’ solutions will enable UCI Health to establish a virtual care platform for remote patient monitoring (RPM) and hospital-at-home initiatives.

COLLABORATION PARTNERSHIP

#institution

#rpm

#virtual care

View Analyst & Ambassador Comments
Go to original news
Mar 10,2022

Leben Salud becomes the first hospital to implement Kaiku Health in South America

Kaiku Health expansion around the world continues as Leben Salud becomes the first user of Kaiku Health in South America. The Argentinian hospital went live with Kaiku Health in November 2021 and currently uses the digital therapeutics platform in radiotherapy. Located in the Patagonia region in Argentina, Leben Salud treats thousands of cancer patients each month. In a region of great distances, Kaiku Health helps the clinic to bring the patients and care teams closer to each other regardless of their location. The dynamic symptom management enables early symptom detection and intervention, and the direct communication channel reduces any uncertainty patients may experience during their treatment. Kaiku Health also educates patients on their self-management strategies. All this is particularly important for patients who may not have easy access to visit their clinic.

COLLABORATION PARTNERSHIP

#institution

#pdt

#rpm

View Analyst & Ambassador Comments
Go to original news
Mar 14,2022

Twill and Zuellig Pharma Partner to Commercialize Prescription Digital Therapeutics in Asia

Today, Happify Health, the Intelligent Healing Company™, announced it has entered into an out-licensing and distribution deal with Zuellig Pharma for two of its digital therapeutics solutions. Zuellig Pharma, one of the largest healthcare services groups in Asia, will license Ensemble, Happify Health’s transdiagnostic prescription digital therapeutic for people with Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD) or both, and also license a Prescription Digital Therapeutics for the treatment of Chronic Insomnia. Zuellig Pharma will be deploying these solutions in 13 countries throughout the region.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 31,2022

Powered by Biofourmis, Blessing Health System Partners Launches Home Hospital Services

Blessing Health System, an integrated rural health system selects Biofourmis, a virtual care and digital therapeutics provider to launch its own home hospital services. As part of the selection, Biofourmis is supporting the health system with its turnkey, end-to-end, home hospital solution for participation in the Rural Home Hospital project. Blessing Health System providers will visit patients in their homes and utilize Biofourmis technology to remotely monitor them using biosensors and a patient-centric companion app.

COLLABORATION PARTNERSHIP

#institution

#connected device

#rpm

View Analyst & Ambassador Comments
Go to original news
May 01,2022

Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune and DreAMLand

Blue Note Therapeutics and Bixink Therapeutics, a bio-subsidiary of KPS, today announced that the companies have entered into an exclusive licensing agreement for the commercialization of Blue Note’s prescription digital therapeutics (PDTs) in South Korea. The agreement includes attune™ and DreAMLand™, Blue Note’s lead PDTs designed to support the mental well-being of patients living with cancer.

COLLABORATION PARTNERSHIP

#institution

#pdt

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 05,2022

MedRhythms and EVERSANA announce partnership to launch and commercialize chronic stroke software-based medical device

MedRhythms, a Portland, Maine-based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music and software to improve walking impairments, announced today that it has initiated its partnership with EVERSANA™, a leading provider of global commercialization services to the life sciences industry, to launch and commercialize MR-001, its patented software-based medical device designed to treat chronic stroke walking deficits. To support its anticipated launch, MedRhythms will utilize EVERSANA's fully integrated commercialization services that include market access, agency services, clinical and commercial field teams, medical science liaisons, channel management, patient services, health economics and outcomes research, and compliance, with each service optimized by data and predictive analytics.

COLLABORATION PARTNERSHIP

#institution

#pdt

#connected device

View Analyst & Ambassador Comments
Go to original news
May 25,2022

Wise Health System Partners with Biofourmis for Continuum-Wide Care-at-Home Initiative

Biofourmis, a Boston-based global leader in virtual care and digital medicine, has announced its engagement with Wise Health System to launch a continuum-wide care-at-home initiative. For Wise Health System’s hospital at home program, select patients who are medically eligible for hospital admission will be asked if they would prefer to be admitted to their home instead. Patients who choose this option will receive a Biofourmis-powered Virtual Bed Kit containing a wearable biosensor that enables continuous monitoring of multiple physiological signals, a blood pressure cuff and a digital tablet pre-loaded with the patient-facing Biovitals Hospital@Home app for communicating by video and text with the care team and viewing a dashboard of their vital signs and other data captured from devices.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION